Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 26, 10:17 AM 2012  
PBR-A RIG ESV CXO NE DO 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for INBP and CSKI ...

Asset Comparison and Correlation

    
       
Investment horizon: 
30 Days (Login to change)
       
 
    
 Integrated Biopharma Inc.  and   China Sky One Medical Inc.
Check Correlation Matrix  
Daily Returns (%)
INBP  CSKI  
Timeline
Assuming 30 trading days horizon, Integrated Biopharma Inc. is expected to generate 35.07 times more return on investment than China. However, Integrated is 35.07 times more volatile than China Sky One Medical Inc.. It trades about 0.2 of its potential returns per unit of risk. China Sky One Medical Inc. is currently generating about -0.02 per unit of risk. If you would invest 3.00 in Integrated Biopharma Inc. on April 26, 2012 and sell it today you would earn a total of 4.00 from holding Integrated Biopharma Inc. or generate 133.33% return on investment over 30 days.

Diversification

Pay attention
Overlapping area represents amount of risk that can be diversified away by holding Integrated Biopharma Inc. and China Sky One Medical Inc. in the same portfolio (assuming nothing else is changed)

Correlation Coefficient

0.0
 Parameters
Time Period1 Month [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns
    
Follow Correlation between INBP and CSKI with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Correlation between INBP and CSKI to your reader
 
Get social with Correlation between INBP and CSKI
 Share Correlation between INBP and CSKI 
Share Share Correlation between INBP and CSKI
    
    
 
       
Predicted Return Density
Expected Daily Returns   
INBP  CSKI  

Integrated Biopharma Inc.

 
    
    
Integrated
Performance
8
Out Of
100
Over 30
Days
92% of all equities and portfolios perform better than Integrated Biopharma Inc.. Compared with the overall equity markets, risk-adjusted returns on investments in Integrated Biopharma Inc. are ranked lower than 8 (%) of all global equities and portfolios over the last 30 days.
    
    
Perrigo vs. Integrated Biopharma Inc.
Herbalife Ltd. vs. Integrated Biopharma Inc.
Auxilium Pharmaceuticals Inc. vs. Integrated Biopharma Inc.
Prestige Brands Holdings Inc. vs. Integrated Biopharma Inc.
USANA Health Sciences Inc. vs. Integrated Biopharma Inc.
Lifevantage Corporation vs. Integrated Biopharma Inc.
  

China Sky One Medical Inc.

 
    
    
China
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days China Sky One Medical Inc. has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
Federal National Mortgage Association vs. China Sky One Medical Inc.
KDDI CORP vs. China Sky One Medical Inc.
SK Innovation vs. China Sky One Medical Inc.
A.P. M vs. China Sky One Medical Inc.
Citigroup Inc. vs. China Sky One Medical Inc.
AngloGold Ashanti Ltd. vs. China Sky One Medical Inc.
       


 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting